PubMed
The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials
Pooyandjoo et al., 2016
Levocarnitine
Amino-acid derivative used for mitochondrial and metabolic support (non-peptide).
Trend index
Overview
Amino-acid derivative used for mitochondrial and metabolic support (non-peptide).
Community
Positive 97% · Neutral 3% · Negative 0%
Median: 2000+ mcg · Most common: 2000+ mcg
Among repeat reporters, 84% said they felt similar to their last entry, 16% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 119 days · Based on 25 repeat reporters
Research
PubMed
Pooyandjoo et al., 2016
PubMed
Mikhailova et al., 2011
ClinicalTrials.gov
ClinicalTrials.gov, 2009
Help
This page summarizes 25 anonymized self-reports from PeptIQ users who track L-Carnitine, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
3 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
This wiki does not assess safety or recommend use. L-Carnitine is listed as Supplement / Rx forms. Consult a licensed clinician for personal medical decisions.
Research, primarily in animal models, suggests L-Carnitine may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceL-Carnitine is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified L-Carnitine as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceThe safety and effectiveness of L-Carnitine have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhile there are over 200 published studies on L-Carnitine, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source